Estrogen receptors in human uterine adenocarcinoma: Correlation with tissue differentiation, vaginal karyopycnotic index, and effect of progestogen or anti-estrogen treatment-Reference-Cited by-同舟云学术

Estrogen receptors in human uterine adenocarcinoma: Correlation with tissue differentiation, vaginal karyopycnotic index, and effect of progestogen or anti-estrogen treatment

Published:1982-08 Issue:1 Volume:14 Page:33-39
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Billiet G.,De Hertogh R.,Bonte J.,Ide P.,Vlaemynck G.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference23 articles.

1. Hormonoprophylaxis and hormonotherapy in the treatment of endometrial adenocarcinoma by means of medroxyprogesterone acetate;Bonte;Gynecol. Oncol.,1978

2. Estradiol binding by human endometrial tissue;Muechler;Gynecol. Oncol.,1975

3. Steroid receptors in normal and neoplastic human uterine tissue;Syrjälä,1978

4. On receptors for estrogens (E2) and androgens (DHT) in human endometrial carcinoma and ovarian tumors;Frieberg;Acta Obstet. Gynecol. Scand.,1978

5. Estrogen receptor concentration in normal and pathological human uterine tissue;Evans;J. Clin. Endocrinol. Metabol.,1974

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study;Gynecologic Oncology;2004-01

2. Oral Medroxyprogesterone Acetate in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Dose-Response Study by the Gynecologic Oncology Group;Journal of Clinical Oncology;1999-06

3. Type I and Type II estrogen and progesterone binding sites in endometrial carcinomas: their value in predicting survival;International Journal of Gynecologic Cancer;1993

4. Growth-promoting effects of progesterone in a human endometrial cancer cell line (Ishikawa-Var I);The Journal of Steroid Biochemistry and Molecular Biology;1992-12

5. Plasminogen activators in endometrial adenocarcinoma;International Journal of Gynecological Cancer;1991-09